CRIPTO and cancer: CRIPTO has also been reported as a functional cancer stem cell marker in head and neck cancers and, more recently, in esophageal squamous cell carcinoma, hepatocellular carcinoma, and post-therapy, recurrent osteotropic prostate cancer [21, 22].